Regeneron shares fall after FDA rejects high-dose eye disease treatment
June 27, 2023 at 16:49 PM EDT
Regeneron said the rejection was "solely due to an ongoing review of inspection findings at a third-party filler."
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
